Abstract
Venous thromboembolic disease in hospitalized patients results in substantial mortality, morbidity, and healthcare resource use. While the true incidence of venous thromboembolism (VTE) is difficult to determine, autopsy studies have shown that 5–10 % of hospital deaths are attributable to pulmonary embolism. Major orthopedic surgery is associated with a very high risk of VTE: without thromboprophylaxis objectively confirmed deep-vein thrombosis may occur in up to 60 % of patients within 2 weeks after lower extremity orthopedic surgery. Between 10 and 30 % of symptomatic VTE events present as proximal deep-vein thrombosis, with the potential to lead to post-thrombotic syndrome or pulmonary embolism. As both symptomatic and subclinical thromboembolism are common in patients undergoing major orthopedic surgery, risk assessment and, where appropriate, thromboprophylaxis should be considered.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kakkar VV, Howe CT, Flanc C, et al. Natural history of postoperative deep-vein thrombosis. Lancet. 1969;2(7614):230–2.
Kakkar V. The diagnosis of deep vein thrombosis using the 125I fibrinogen test. Arch Surg. 1972;104:152–9.
Lindblad B, Eriksson A, Bergqvist D. Autopsy-verified pulmonary embolism in a surgical department: analysis of the period from 1951 to 1988. Br J Surg. 1991;78(7):849–52.
Stein PD, Henry JW. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest. 1995;108(4):978–81.
Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125(1):1–7.
Cushman M, Tsai AW, White RH, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology. Am J Med. 2004;117(1):19–25.
Heit JA, Mohr DN, Silverstein MD, et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med. 2000;160(6):761–8.
Mohr DN, Silverstein MD, Heit JA, et al. The venous stasis syndrome after deep venous thrombosis or pulmonary embolism: a population-based study. Mayo Clin Proc. 2000;75(12):1249–56.
McColl MD, Ellison J, Greer IA, et al. Prevalence of the post-thrombotic syndrome in young women with previous venous thromboembolism. Br J Haematol. 2000;108(2):272–4.
Lynch AF, Bourne RB, Rorabeck CH, et al. Deep-vein thrombosis and continuous passive motion after total knee arthroplasty. J Bone Joint Surg Am. 1988;70(1):11–4.
Stringer MD, Steadman CA, Hedges AR, et al. Deep vein thrombosis after elective knee surgery. An incidence study in 312 patients. J Bone Joint Surg Br. 1989;71(3):492–7.
Stulberg BN, Insall JN, Williams GW, et al. Deep-vein thrombosis following total knee replacement. An analysis of six hundred and thirty-eight arthroplasties. J Bone Joint Surg Am. 1984;66(2):194–201.
Haas SB, Insall JN, Scuderi GR, et al. Pneumatic sequential-compression boots compared with aspirin prophylaxis of deep-vein thrombosis after total knee arthroplasty. J Bone Joint Surg Am. 1990;72(1):27–31.
Lotke PA, Ecker ML, Alavi A, et al. Indications for the treatment of deep venous thrombosis following total knee replacement. J Bone Joint Surg Am. 1984;66(2):202–8.
Lynch JA, Baker PL, Polly RE, et al. Mechanical measures in the prophylaxis of postoperative thromboembolism in total knee arthroplasty. Clin Orthop Relat Res. 1990;260:24–9.
Lindblad B, Sternby NH, Bergqvist D. Incidence of venous thromboembolism verified by necropsy over 30 years. BMJ. 1991;302(6778):709–11.
Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patients: are we detecting enough deep vein thrombosis? J R Soc Med. 1989;82(4):203–5.
Alikhan R, Peters F, Wilmott R, et al. Fatal pulmonary embolism in hospitalised patients: a necropsy review. J Clin Pathol. 2004;57(12):1254–7.
Hauch O, Jorgensen LN, Khattar SC, et al. Fatal pulmonary embolism associated with surgery. An autopsy study. Acta Chir Scand. 1990;156(11–12):747–9.
Goldhaber SZ, Turpie AG. Prevention of venous thromboembolism among hospitalized medical patients. Circulation. 2005;111(1):e1–3.
Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6 Suppl):381S–453.
Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(3 Suppl):338S–400.
Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med. 2000;160(6):809–15.
Heit JA, O’Fallon WM, Petterson TM, et al. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Intern Med. 2002;162(11):1245–8.
Ginsberg JS, Turkstra F, Buller HR, et al. Postthrombotic syndrome after hip or knee arthroplasty: a cross-sectional study. Arch Intern Med. 2000;160(5):669–72.
Kim YH, Oh SH, Kim JS. Incidence and natural history of deep-vein thrombosis after total hip arthroplasty. A prospective and randomised clinical study. J Bone Joint Surg Br. 2003;85(5):661–5.
Collins R, Scrimgeour A, Yusuf S, et al. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med. 1988;318(18):1162–73.
Bergqvist D. Postoperative thromboembolism. New York: Springer; 1983.
Paiement GD, Bell D, Wessinger SJ, editors. New advances in the prevention, diagnosis, and cost effectiveness of venous thromboembolic disease in patients with total hip replacement. In: The hip, proceedings of the fourteenth open scientific meeting of the Hip Society, C.V. Mosby, Saint Louis, 1987, p. 94–119.
Leclerc JR, Gent M, Hirsh J, et al. The incidence of symptomatic venous thromboembolism after enoxaparin prophylaxis in lower extremity arthroplasty: a cohort study of 1,984 patients. Canadian Collaborative Group. Chest. 1998;114(2 Suppl Evidence):115S–8.
Dahl OE, Gudmundsen TE, Haukeland L. Late occurring clinical deep vein thrombosis in joint-operated patients. Acta Orthop Scand. 2000;71(1):47–50.
Colwell Jr CW, Collis DK, Paulson R, et al. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge. J Bone Joint Surg Am. 1999;81(7):932–40.
Heit JA, Elliott CG, Trowbridge AA, et al. Ardeparin sodium for extended out-of-hospital prophylaxis against venous thromboembolism after total hip or knee replacement. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2000;132(11):853–61.
Schiff RL, Kahn SR, Shrier I, et al. Identifying orthopedic patients at high risk for venous thromboembolism despite thromboprophylaxis. Chest. 2005;128(5):3364–71.
White RH, Romano PS, Zhou H, et al. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med. 1998;158(14):1525–31.
Warwick D, Friedman RJ, Agnelli G, et al. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: findings from the Global Orthopaedic Registry. J Bone Joint Surg Br. 2007;89(6):799–807.
Planes A, Vochelle N, Darmon JY, et al. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: double-blind randomised comparison of enoxaparin versus placebo. Lancet. 1996;348(9022):224–8.
Kearon C. Natural history of venous thromboembolism. Semin Vasc Med. 2001;1(1):27–38.
Cordell-Smith JA, Williams SC, Harper WM, et al. Lower limb arthroplasty complicated by deep venous thrombosis. Prevalence and subjective outcome. J Bone Joint Surg Br. 2004;86(1):99–101.
Pellegrini Jr VD, Donaldson CT, Farber DC, et al. The Mark Coventry Award: prevention of readmission for venous thromboembolism after total knee arthroplasty. Clin Orthop Relat Res. 2006;452:21–7.
McKenna R, Galante J, Bachmann F, et al. Prevention of venous thromboembolism after total knee replacement by high-dose aspirin or intermittent calf and thigh compression. Br Med J. 1980;280(6213):514–7.
Morrey BF, Adams RA, Ilstrup DM, et al. Complications and mortality associated with bilateral or unilateral total knee arthroplasty. J Bone Joint Surg Am. 1987;69(4):484–8.
Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89(4):780–5.
Pellegrini Jr VD, Donaldson CT, Farber DC, et al. The John Charnley Award: prevention of readmission for venous thromboembolic disease after total hip arthroplasty. Clin Orthop Relat Res. 2005;441:56–62.
Lieberman JR, Hsu WK. Prevention of venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am. 2005;87(9):2097–112.
Lijfering WM, van der Meer J. Pharmacological prevention of venous thromboembolism. In: van Beek JR, Buller HR, Oudkerk M, editors. Deep vein thrombosis and pulmonary embolism. Chichester: John Wiley and Sons, Ltd; 2009. p. 435–61.
Salvati EA, Pellegrini Jr VD, Sharrock NE, et al. Recent advances in venous thromboembolic prophylaxis during and after total hip replacement. J Bone Joint Surg Am. 2000;82(2):252–70.
Phillips CB, Barrett JA, Losina E, et al. Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip replacement. J Bone Joint Surg Am. 2003;85-A(1):20–6.
Dahl OE, Caprini JA, Colwell Jr CW, et al. Fatal vascular outcomes following major orthopedic surgery. Thromb Haemost. 2005;93(5):860–6.
Howie C, Hughes H, Watts AC. Venous thromboembolism associated with hip and knee replacement over a ten-year period: a population-based study. J Bone Joint Surg Br. 2005;87(12):1675–80.
Warwick D, Williams MH, Bannister GC. Death and thromboembolic disease after total hip replacement. A series of 1162 cases with no routine chemical prophylaxis. J Bone Joint Surg Br. 1995;77(1):6–10.
Fender D, Harper WM, Thompson JR, et al. Mortality and fatal pulmonary embolism after primary total hip replacement. Results from a regional hip register. J Bone Joint Surg Br. 1997;79(6):896–9.
Gillespie W, Murray D, Gregg PJ, et al. Risks and benefits of prophylaxis against venous thromboembolism in orthopaedic surgery. J Bone Joint Surg Br. 2000;82(4):475–9.
Turpie AG, Levine MN, Hirsh J, et al. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med. 1986;315(15):925–9.
Seagroatt V, Tan HS, Goldacre M, et al. Elective total hip replacement: incidence, emergency readmission rate, and postoperative mortality. BMJ. 1991;303(6815):1431–5.
Hitos K, Fletcher JP. Venous thromboembolism and fractured neck of femur. Thromb Haemost. 2005;94(5):991–6.
Riska EB. Incidence of thrombo-embolic disease in patients with hip fractures. Injury. 1970;2(2):155–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Kakkar, A.K., Rushton-Smith, S.K. (2013). Incidence of Venous Thromboembolism in Orthopedic Surgery. In: Llau, J. (eds) Thromboembolism in Orthopedic Surgery. Springer, London. https://doi.org/10.1007/978-1-4471-4336-9_2
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4336-9_2
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4335-2
Online ISBN: 978-1-4471-4336-9
eBook Packages: MedicineMedicine (R0)